快网 RDNT 深 沪
已收盘 07-02 16:00:00 美东时间
68.75
+3.130
+4.77%
华盛通- 最 高70.00
- 今 开66.12
- 成交量 171.76万股
- 最 低 65.32
- 昨 收 65.62
- 总市值 54.06亿
- 52周最高 85.84
- 市盈率 静 --
- 换手率 2.18%
- 52周最低 50.76
- 委 比 24.34%
- 总股本 7863.42万
- 历史最高 93.65
- 量 比 1.32
- 振 幅 7.13%
- 历史最低 1.50
- 每 手 1
- 风险率 9.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Cava、CrowdStrike、Keysight获多家大行上调目标价；家得宝绩后遭多家大行下调目标价
今日重点评级关注：Oppenheimer：维持Protara Therapeutics"跑赢大市"评级，目标价从25美元升至28美元；Piper Sandler：维持Bright Minds Biosciences"超配"评级，目标价从190美元升至220美元
05-21 12:05
Barclays Maintains Overweight on RadNet, Lowers Price Target to $65
Barclays analyst Andrew Mok maintains RadNet (NASDAQ:RDNT) with a Overweight and lowers the price target from $70 to $65.
05-20 21:56
RadNet shares are trading higher after the company reported better-than-expected Q1 sales results and raised its FY26 sales guidance above estimates.
RadNet shares are trading higher after the company reported better-than-expecte...
05-11 19:35
RadNet Raises FY2026 Sales Guidance from $2.460B-$2.520B to $2.490B-$2.550B vs $2.456B Est
RadNet (NASDAQ:RDNT) raises FY2026 sales outlook from $2.460 billion-$2.520 billion to $2.490 billion-$2.550 billion vs $2.456 billion estimate.
05-11 15:47
RadNet Q1 Adj. EPS $(0.28) Misses $(0.19) Estimate, Sales $575.631M Beat $557.971M Estimate
RadNet (NASDAQ:RDNT) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.19) by 47.37 percent. This is a 20 percent increase over losses of $(0.35) per share from the same
05-11 15:35
RadNet Forms JV With Saint Alphonsus Health System In Idaho To Operate Three Multimodality Outpatient Imaging Centers
RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today the formation of a joint
05-01 04:24
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
Barclays Maintains Overweight on RadNet, Lowers Price Target to $70
Barclays analyst Andrew Mok maintains RadNet (NASDAQ:RDNT) with a Overweight and lowers the price target from $86 to $70.
04-21 22:30
财报速睇 | 快网 2025财年年度营收20.40亿美元，同比增长11.5%；归母净利润亏损0.19亿美元，由盈转亏
华盛资讯3月3日讯，快网公布2025财年年度业绩，公司年度营收20.40亿美元，同比增长11.5%，归母净利润亏损0.19亿美元，由盈转亏。
03-03 08:07
RadNet shares are trading higher after the company reported better-than-expected Q4 financial results.
RadNet shares are trading higher after the company reported better-than-expecte...
03-03 03:38
